|
05/08/2003
MediVision American Subsidiary signs Licensing Agreement
with NextGen
OIS to Sell NextGen Healthcare Products in the Ophthalmic
Market
Yokneam Elit, Israel, MediVision Medical Imaging Ltd. (EURO.NM: MEDV, the
'company') announced today (August 5, 2003) that it's American subsidiary,
Ophthalmic Imaging Systems ('OIS') (OTCBB: OISI) has signed a reseller agreement
with NextGen Healthcare Information Systems, Inc., a subsidiary of Quality
Systems, Inc. (NASDAQ: QSII). Under the terms of the agreement, OIS was
appointed as a reseller in the US of two computer-based practice management and
medical records products: NextGen® Enterprise Practice Management (EPM) and
NextGen® Electronic Medical Records (EMR).
The Company views this as a strategic business alliance intended to diversify
OIS' product portfolio and, enable it to offer a wider variety of products and
comprehensive solutions to its customer base of ophthalmology departments and
practices in the US. The agreement gives NextGen Healthcare the opportunity to
partner with OIS, one of the leaders in providing high quality products to the
American ophthalmic market for more than 19 years.
'We are very excited to be selling NextGen Healthcare information management
systems to our American customers,' said Noam Allon, President and Chief
Executive Officer of MediVision. 'NextGen Healthcare is one of the most
innovative medical software companies supplying comprehensive solutions that
help reduce administrative costs and enhance information access. Using NextGen®
Electronic Medical Records software, combined with the NextGen® Electronic
Practice Management package on one hand, and our comprehensive imaging solution
integrated with hospital Picture Archiving and Communication Systems (PACS),
which is supplied as part of our relationship with Agfa, allows OIS to provide
the ophthalmic community with a comprehensive imaging and practice management
solution. A seamless integration of such components is expected to offer the
best solution currently available in the market. We expect that this agreement
will have a significant impact on the company's growth.'
The NextGen® EMR system creates and maintains complete medical records with
minimal effort while it streamlines workflow, controls utilization, and manages
critical data related to patient care outcomes. The NextGen® EPM system is a
complete physician management system that provides a common registration system,
enterprise-wide appointment scheduling, referral tracking, clinical support, a
custom report writer, and patient financial management based on a managed care
model. The NextGen® EMR & NextGen® EPM products enhance the Ophthalmic PACS
solutions already offered by OIS to its customers in collaboration with Agfa
Healthcare.
Ophthalmic Imaging Systems, a majority-owned subsidiary of MediVision, is a
leading provider of ophthalmic digital imaging systems. OIS designs, develops,
manufactures and markets digital imaging systems for the eye care market. With
over nineteen years in the ophthalmic imaging business, OIS has consistently
introduced new, innovative technology. OIS, together with MediVision, co-market
and support their products worldwide through an extensive network of dealers,
distributors, and direct representatives.
NextGen Healthcare Information Systems, Inc. is a wholly owned subsidiary of
Quality Systems, Inc. (QSII:NASDAQ), one of the leading developers and providers
of computer-based practice management and electronic medical records systems for
medical and dental group practices. In business for more than 25 years, QSI is
profitable and has a history of financial health and customer service. Website:
www.nextgen.com, for additional information.
About MediVision
MediVision specializes in digital imaging devices for
ophthalmic applications with an emphasis on diagnostics related to the eye
retina. MediVision's products are designed to provide digital upgrades for a
range of ophthalmic imaging systems, thus significantly enhancing imaging
capability and providing its users with advanced diagnostic tools. The company's
goals are to achieve significant market share and be a market leader in the
ophthalmic digital imaging field.
The company owns a 85% interest in Ophthalmic Imaging Systems Inc. based in
Sacramento, California, USA.
This Release contains certain forward-looking statements and information
relating to the Company that are based on the beliefs of the Management of the
Company as well as assumptions made by and information currently available to
the Management of the Company. Such statements reflect the current views of the
Company with respect to future events, the outcome of which is subject to
certain risks and other factors, which may be outside of the Company's control.
Should one or more of these risks or uncertainties materialize, or should
underlying assumptions prove incorrect, actual results of outcomes may vary
materially from those described herein as projected, anticipated, believed,
estimated, expected or intended.
For more information, please
contact :
Ariel Shenhar
MediVision Medical Imaging Ltd.
Vice President, Chief Financial Officer
Tel. ++972-4-9894884
Fax ++972-4-9894883
cel. ++972-52-821728
P.O. Box 45, Yokneam Elit
Industrial Park 20692, Israel
ariel@medivision-ois.com
|
